3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
55
Prostatic Neoplasms
46
Glioblastoma
28
Brain Neoplasms
25
Neoplasms
23
Glioma
21
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
18
Carcinoma, Hepatocellular
14
Gliosarcoma
13
Colorectal Neoplasms
12
Uterine Cervical Neoplasms
11
Neoplasm Metastasis
11
Rectal Neoplasms
10
Lymphoma, Non-Hodgkin
10
Oligodendroglioma
9
Melanoma
9
Central Nervous System Neoplasms
9
Astrocytoma
9
Lymphoma
8
Head and Neck Neoplasms
8
Esophageal Neoplasms
8
Colonic Neoplasms
8
Ependymoma
7
Squamous Cell Carcinoma of Head and Neck
6
Pancreatic Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
6
Carcinoma, Renal Cell
6
Breast Neoplasms, Male
6
Ovarian Neoplasms
5
Interventions
siltuximab
1
otelixizumab
1
fludarabine
1
axicabtagene ciloleucel
1
Neuropsychological Tests
1
Magnetic Resonance Spectroscopy
1
Leukapheresis
1
Interleukin 1 Receptor Antagonist Protein
1
Gelsolin
1
Cyclophosphamide
1
Contrast Media
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Cytokine Release Syndrome
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled